Search research articles
Contact Us
Filters
Showing results (541-550 of 927) with videos related to
Page
of 93
Sort By:
Circulation
|
May 7, 2008
Torcetrapib does not reduce atherosclerosis beyond atorvastatin and induces more proinflammatory lesions than atorvastatin
Willeke de Haan, Jitske de Vries-van der Weij, José W A van der Hoorn, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
August 10, 2010
Incremental prognostic value of left ventricular function analysis over non-invasive coronary angiography with multidetector computed tomography
Fleur R de Graaf, Jacob M van Werkhoven, Joëlla E van Velzen, et al.
Atherosclerosis
|
February 12, 2008
Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in PROSPER
Eliana Polisecki, Hind Muallem, Nobuyo Maeda, et al.
European Journal of Preventive Cardiology
|
February 8, 2025
Apolipoprotein C3 and risk of cardiovascular events and death in patients on optimized statin treatment after recent acute coronary syndrome
Gregory G Schwartz, Michael Szarek, Esther Reijnders, et al.
Journal of the American College of Cardiology
|
December 19, 2006
Relationship between noninvasive coronary angiography with multi-slice computed tomography and myocardial perfusion imaging
Joanne D Schuijf, William Wijns, J Wouter Jukema, et al.
Circulation. Genomic and Precision Medicine
|
April 2, 2021
Role of Adenylate Cyclase 9 in the Pharmacogenomic Response to Dalcetrapib: Clinical Paradigm and Molecular Mechanisms in Precision Cardiovascular Medicine
David Rhainds, Chris J Packard, Mathieu R Brodeur, et al.
European Journal of Preventive Cardiology
|
March 19, 2024
Comparison of change in lipoprotein(a) mass and molar concentrations by alirocumab and risk of subsequent cardiovascular events in ODYSSEY OUTCOMES
Michael Szarek, Esther Reijnders, Ph Gabriel Steg, et al.
Circulation
|
November 15, 2017
Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)
Marc P Bonaca, Patrice Nault, Robert P Giugliano, et al.
Atherosclerosis
|
April 27, 2017
Inhibition of 14q32 microRNA miR-495 reduces lesion formation, intimal hyperplasia and plasma cholesterol levels in experimental restenosis
Sabine M J Welten, Rob C M de Jong, Anouk Wezel, et al.
Journal of the American College of Cardiology
|
March 26, 2024
Effect of Sodium-Glucose Cotransporter 2 Inhibitors in Adults With Congenital Heart Disease
Ralph M L Neijenhuis, Simon T MacDonald, Filip Zemrak, et al.
Page
of 93
Search research articles
Search
Showing results (541-550 of 927) with videos related to
Sort By:
Page
of 93
Circulation
|
May 7, 2008
Torcetrapib does not reduce atherosclerosis beyond atorvastatin and induces more proinflammatory lesions than atorvastatin
Willeke de Haan, Jitske de Vries-van der Weij, José W A van der Hoorn, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
August 10, 2010
Incremental prognostic value of left ventricular function analysis over non-invasive coronary angiography with multidetector computed tomography
Fleur R de Graaf, Jacob M van Werkhoven, Joëlla E van Velzen, et al.
Atherosclerosis
|
February 12, 2008
Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in PROSPER
Eliana Polisecki, Hind Muallem, Nobuyo Maeda, et al.
European Journal of Preventive Cardiology
|
February 8, 2025
Apolipoprotein C3 and risk of cardiovascular events and death in patients on optimized statin treatment after recent acute coronary syndrome
Gregory G Schwartz, Michael Szarek, Esther Reijnders, et al.
Journal of the American College of Cardiology
|
December 19, 2006
Relationship between noninvasive coronary angiography with multi-slice computed tomography and myocardial perfusion imaging
Joanne D Schuijf, William Wijns, J Wouter Jukema, et al.
Circulation. Genomic and Precision Medicine
|
April 2, 2021
Role of Adenylate Cyclase 9 in the Pharmacogenomic Response to Dalcetrapib: Clinical Paradigm and Molecular Mechanisms in Precision Cardiovascular Medicine
David Rhainds, Chris J Packard, Mathieu R Brodeur, et al.
European Journal of Preventive Cardiology
|
March 19, 2024
Comparison of change in lipoprotein(a) mass and molar concentrations by alirocumab and risk of subsequent cardiovascular events in ODYSSEY OUTCOMES
Michael Szarek, Esther Reijnders, Ph Gabriel Steg, et al.
Circulation
|
November 15, 2017
Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)
Marc P Bonaca, Patrice Nault, Robert P Giugliano, et al.
Atherosclerosis
|
April 27, 2017
Inhibition of 14q32 microRNA miR-495 reduces lesion formation, intimal hyperplasia and plasma cholesterol levels in experimental restenosis
Sabine M J Welten, Rob C M de Jong, Anouk Wezel, et al.
Journal of the American College of Cardiology
|
March 26, 2024
Effect of Sodium-Glucose Cotransporter 2 Inhibitors in Adults With Congenital Heart Disease
Ralph M L Neijenhuis, Simon T MacDonald, Filip Zemrak, et al.
Page
of 93